uniQure NV QURE 深 沪
已收盘 08-07 16:00:00 美东时间
46.42
+1.060
+2.34%
华盛通- 最 高48.105
- 今 开46.35
- 成交量 179.17万股
- 最 低 42.56
- 昨 收 45.36
- 总市值 216.54万
- 52周最高 71.50
- 市盈率 静 6.60
- 换手率 3840.99%
- 52周最低 8.73
- 委 比 -94.97%
- 总股本 4.66万
- 历史最高 82.49
- 量 比 1.41
- 振 幅 12.22%
- 历史最低 1.10
- 每 手 1
- 风险率 14.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多uniQure's Experimental Drug Shows Early Promise In Difficult-To-Treat Epilepsy
uniQure reported early seizure reductions in an AMT-260 epilepsy study, with no treatment-related serious adverse events.
06-22 23:51
Crude Oil Edges Higher; US Retail Sales Top Estimates
U.S. stocks up, Dow Jones gains 0.39%. NASDAQ rose 0.09%, S&P 500 up 0.11%. Industrials shares jump 0.9%, while communication services fall 1.7%.
06-18 00:06
FDA Signals uniQure Huntington Gene Therapy Data Could Back Accelerated Approval
uniQure stock surged after the FDA said three-year AMT-130 data could support accelerated approval for Huntington's disease treatment.
06-17 22:31
'Makary's Time Atop FDA Over, Diamantas Named Acting Commissioner' - Politico
https://subscriber.politicopro.com/article/2026/05/makarys-time-atop-fda-over-tktk-named-acting-commissioner-00916014
05-13 00:49
FDA Official Calls UniQure's Gene Therapy A "Failed" Treatment For Huntington's Disease - CNBC
https://www.cnbc.com/2026/03/05/fda-uniqure-gene-therapy-huntingtons-disease.html
03-06 04:04
Crude Oil Rises Sharply; Sealed Air Posts Upbeat Earnings
Dow Jones down 0.46% amid Iran-U.S. conflict, NASDAQ down 0.22% and S&P 500 down 0.39%. Energy sector up 1.8%, consumer discretionary down 1.7%. Sealed Air Corp beats earnings expectations. The Dow Jones is down 0.46%, NASDAQ is down 0.22%, and S&P 500 is down 0.39%. Energy sector up 1.8% while consumer discretionary is down 1.7%. Sealed Air Corp surpasses earnings expectations.
03-03 01:08
Dow Falls 150 Points; ISM Manufacturing PMI Edges Lower In February
Stocks fall in US, Dow drops 150 points. Energy sector up, consumer discretionary down. ISM and S&P PMIs decline but beat estimates. Asian markets close lower.
03-02 23:17
uniQure Stock Plunges 40% After FDA Shocker
FDA urges uniQure to run a new trial for AMT-130, sending QURE shares down nearly 40% in premarket trading.
03-02 21:51
uniQure Q4 Earnings Summary & Key Takeaways
uniQure (NASDAQ:QURE) just disclosed its Q4 earnings on Monday, March 2, 2026 a...
03-02 20:12
Earnings Scheduled For March 2, 2026
Companies Reporting Before The Bell • Zymeworks (NASDAQ:ZYME) is expected to re...
03-02 19:11
